NCT02475265|CompletedPhase 2Results
Transdermal Estrogen in Older Premenopausal Women With Anorexia Nervosa
1180
Loading search results
Sponsor study identifier
Secondary identifiers
NIH
interventional
11
1 country
1
Study Start
July 2015
Actual (reported)Primary Completion
June 27, 2018
Actual (reported)Study Completion
July 30, 2018
Actual (reported)Decreased bone strength is a common and serious medical problem present in many women with anorexia nervosa. Women with decreased bone strength are more likely to suffer broken bones than women with normal bone strength. This study will investigate whether the use of transdermal estrogen can improve bone mineral density (BMD) and bone microarchitecture in women with anorexia nervosa anorexia nervosa when used for 6 months.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 30, 2018
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 10, 2015
Actual (reported)June 18, 2015
Actual (reported)July 2015
Actual (reported)June 27, 2018
Actual (reported)July 30, 2018
Actual (reported)July 22, 2019
Actual (reported)Percent Change in Bone Mineral Density (BMD) of Lumbar Spine by Dual Energy X-ray Absorptiometry (DXA)
Percent change in lumbar spine bone mineral density after six-months. Lumbar spine bone mineral density measured by dual energy x-ray absorptiometry.
6 months
6 months of estradiol 0.045mg/levonorgestrel 0.015mg (once weekly patch).
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
These entries preserve how the registry describes the intervention. Their treatment roles are shown separately from molecular identities.
Grouped treatment entry
estradiol 0.045 mg/levonorgestrel 0.015mg
The registry names several treatments. This does not confirm that participants received them together or that they form a single product.
View registry recordMassachusetts General Hospital
Boston, Massachusetts, 02114, United States
Pouneh K Fazeli, MD
MGH/Harvard Medical School
11 participants (actual enrollment reported by the registry).
First Submitted
June 10, 2015
First Posted
June 18, 2015
Study Start
July 2015
Actual (reported)Bone Mass Changes in Anorexia Nervosa Patient Followed During 4 Years
Contact the study team to confirm eligibility.
Primary Completion
June 27, 2018
Actual (reported)Study Completion
July 30, 2018
Actual (reported)Last Updated
July 22, 2019
Results First Posted
July 22, 2019
Record last verified: 2019-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: